Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1067928812 | 10679288 | 12 | F | 20150625 | 20160912 | 20141229 | 20160923 | EXP | CA-INCYTE CORPORATION-2013IN002396 | INCYTE | 80.82 | YR | F | Y | 0.00000 | 20160923 | CN | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1067928812 | 10679288 | 1 | PS | JAKAFI | RUXOLITINIB | 1 | Oral | 10 MG, BID | N | 202192 | 10 | MG | TABLET | BID | |||||
| 1067928812 | 10679288 | 2 | SS | JAKAFI | RUXOLITINIB | 1 | Oral | 3 DF, TID | N | 202192 | 3 | DF | TABLET | TID | |||||
| 1067928812 | 10679288 | 3 | SS | JAKAFI | RUXOLITINIB | 1 | Oral | 2 DF, BID | N | 202192 | 2 | DF | TABLET | BID | |||||
| 1067928812 | 10679288 | 4 | SS | JAKAFI | RUXOLITINIB | 1 | Oral | 5 MG, BID | N | 202192 | 5 | MG | TABLET | BID | |||||
| 1067928812 | 10679288 | 5 | SS | JAKAFI | RUXOLITINIB | 1 | Oral | 15 MG, QD (1 PILL OF 5 MG QAM AND 2 PILLS OF 5 MG QPM) | N | 202192 | TABLET | ||||||||
| 1067928812 | 10679288 | 6 | SS | JAKAFI | RUXOLITINIB | 1 | Oral | 20 MG, QD (2 PILLS OF 5 MG IN THE MORNING AND 2 PILLS OF 5 MG IN THE EVENING) | N | 202192 | TABLET | ||||||||
| 1067928812 | 10679288 | 7 | SS | JAKAFI | RUXOLITINIB | 1 | Oral | 15 MG, QD (1 PILL OF 5 MG QAM AND 2 PILLS OF 5 MG QPM) | N | 202192 | TABLET | ||||||||
| 1067928812 | 10679288 | 8 | SS | JAKAFI | RUXOLITINIB | 1 | Oral | 5 MG, BID | N | 202192 | 5 | MG | TABLET | BID | |||||
| 1067928812 | 10679288 | 9 | SS | VOLTAREN | DICLOFENAC SODIUM | 1 | Topical | UNK UNK, QD (2-3 TIMES) | 0 | CREAM | |||||||||
| 1067928812 | 10679288 | 10 | C | LIPITOR | ATORVASTATIN CALCIUM | 1 | Unknown | UNK | U | 0 | |||||||||
| 1067928812 | 10679288 | 11 | C | ASA | ASPIRIN | 1 | Unknown | UNK | U | U | 0 | ||||||||
| 1067928812 | 10679288 | 12 | C | ASA | ASPIRIN | 1 | Unknown | 81 MG, QD | U | U | 0 | 81 | MG | QD | |||||
| 1067928812 | 10679288 | 13 | C | ASA | ASPIRIN | 1 | 81 MG, QD | U | U | 0 | 81 | MG | QD | ||||||
| 1067928812 | 10679288 | 14 | C | CALCIUM | CALCIUM | 1 | Unknown | UNK | U | U | 0 | ||||||||
| 1067928812 | 10679288 | 15 | C | CALCIUM | CALCIUM | 1 | Unknown | UNK | U | U | 0 | ||||||||
| 1067928812 | 10679288 | 16 | C | CITALOPRAM | CITALOPRAM HYDROBROMIDE | 1 | Unknown | UNK | N | U | 0 | ||||||||
| 1067928812 | 10679288 | 17 | C | CITALOPRAM | CITALOPRAM HYDROBROMIDE | 1 | Unknown | 20 MG, QD | N | U | 0 | 20 | MG | QD | |||||
| 1067928812 | 10679288 | 18 | C | CITALOPRAM | CITALOPRAM HYDROBROMIDE | 1 | Unknown | 10 MG, QD | N | U | 0 | 10 | MG | QD | |||||
| 1067928812 | 10679288 | 19 | C | CITALOPRAM | CITALOPRAM HYDROBROMIDE | 1 | Unknown | 20 MG, QD | N | U | 0 | 20 | MG | QD | |||||
| 1067928812 | 10679288 | 20 | C | CITALOPRAM | CITALOPRAM HYDROBROMIDE | 1 | Unknown | 10 MG, QD | N | U | 0 | 10 | MG | QD | |||||
| 1067928812 | 10679288 | 21 | C | CITALOPRAM | CITALOPRAM HYDROBROMIDE | 1 | Unknown | 20 MG, QD | N | U | 0 | 20 | MG | QD | |||||
| 1067928812 | 10679288 | 22 | C | CITALOPRAM | CITALOPRAM HYDROBROMIDE | 1 | Unknown | 10 MG, QD | N | U | 0 | 10 | MG | QD | |||||
| 1067928812 | 10679288 | 23 | C | CITALOPRAM | CITALOPRAM HYDROBROMIDE | 1 | Unknown | 20 MG, QD | N | U | 0 | 20 | MG | QD | |||||
| 1067928812 | 10679288 | 24 | C | CITALOPRAM | CITALOPRAM HYDROBROMIDE | 1 | Unknown | 10 MG, QD | N | U | 0 | 10 | MG | QD | |||||
| 1067928812 | 10679288 | 25 | C | CITALOPRAM | CITALOPRAM HYDROBROMIDE | 1 | Unknown | 20 MG, QD | N | U | 0 | 20 | MG | QD | |||||
| 1067928812 | 10679288 | 26 | C | CITALOPRAM | CITALOPRAM HYDROBROMIDE | 1 | Unknown | 10 MG, QD | N | U | 0 | 10 | MG | QD | |||||
| 1067928812 | 10679288 | 27 | C | CELEBREX | CELECOXIB | 1 | Unknown | UNK | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 1067928812 | 10679288 | 1 | Myelofibrosis |
| 1067928812 | 10679288 | 9 | Arthritis |
| 1067928812 | 10679288 | 10 | Product used for unknown indication |
| 1067928812 | 10679288 | 11 | Product used for unknown indication |
| 1067928812 | 10679288 | 14 | Product used for unknown indication |
| 1067928812 | 10679288 | 16 | Product used for unknown indication |
| 1067928812 | 10679288 | 27 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 1067928812 | 10679288 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 1067928812 | 10679288 | Abdominal distension | |
| 1067928812 | 10679288 | Anaemia | |
| 1067928812 | 10679288 | Arthralgia | |
| 1067928812 | 10679288 | Contusion | |
| 1067928812 | 10679288 | Drug ineffective | |
| 1067928812 | 10679288 | Dry mouth | |
| 1067928812 | 10679288 | Fatigue | |
| 1067928812 | 10679288 | Flatulence | |
| 1067928812 | 10679288 | Increased appetite | |
| 1067928812 | 10679288 | Initial insomnia | |
| 1067928812 | 10679288 | Loss of consciousness | |
| 1067928812 | 10679288 | Muscle spasms | |
| 1067928812 | 10679288 | Neuralgia | |
| 1067928812 | 10679288 | Pain | |
| 1067928812 | 10679288 | Pain in extremity | |
| 1067928812 | 10679288 | Peripheral swelling | |
| 1067928812 | 10679288 | Peripheral vascular disorder | |
| 1067928812 | 10679288 | Platelet count decreased | |
| 1067928812 | 10679288 | Pruritus | |
| 1067928812 | 10679288 | Renal pain | |
| 1067928812 | 10679288 | Vascular rupture | |
| 1067928812 | 10679288 | Vomiting | |
| 1067928812 | 10679288 | Weight increased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 1067928812 | 10679288 | 1 | 20130815 | 0 | ||
| 1067928812 | 10679288 | 4 | 20131126 | 0 |